Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
89.65
+2.32 (2.66%)
At close: Dec 5, 2025, 4:00 PM EST
89.00
-0.65 (-0.73%)
After-hours: Dec 5, 2025, 6:37 PM EST
Protagonist Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5,605 | 2,300 | 1,323 | 537 | 1,632 | 867 | |
| Market Cap Growth | 143.30% | 73.94% | 146.40% | -67.12% | 88.22% | 352.15% | |
| Enterprise Value | 4,936 | 1,728 | 1,002 | 274 | 1,286 | 674 | |
| Last Close Price | 89.65 | 38.60 | 22.93 | 10.91 | 34.20 | 20.16 | |
| PE Ratio | 124.48 | 8.36 | - | - | - | - | |
| PS Ratio | 27.06 | 5.30 | 22.04 | 20.19 | 59.67 | 30.29 | |
| PB Ratio | 8.67 | 3.41 | 3.93 | 2.49 | 5.44 | 3.10 | |
| P/TBV Ratio | 8.68 | 3.41 | 3.93 | 2.49 | 5.44 | 3.10 | |
| P/FCF Ratio | 87.97 | 12.59 | - | - | - | - | |
| P/OCF Ratio | 85.61 | 12.49 | - | - | - | - | |
| EV/Sales Ratio | 23.59 | 3.98 | 16.69 | 10.29 | 47.01 | 23.53 | |
| EV/EBITDA Ratio | 246.45 | 6.81 | - | - | - | - | |
| EV/EBIT Ratio | 259.70 | 6.84 | - | - | - | - | |
| EV/FCF Ratio | 77.48 | 9.45 | - | - | - | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.00 | 0.02 | 0.02 | 0.02 | |
| Debt / EBITDA Ratio | 0.47 | 0.04 | - | - | - | - | |
| Debt / FCF Ratio | 0.17 | 0.06 | - | - | - | - | |
| Asset Turnover | 0.32 | 0.79 | 0.20 | 0.09 | 0.08 | 0.12 | |
| Quick Ratio | 12.94 | 12.39 | 16.54 | 7.61 | 7.55 | 7.69 | |
| Current Ratio | 13.05 | 12.48 | 16.71 | 7.80 | 7.74 | 7.84 | |
| Return on Equity (ROE) | 7.80% | 54.39% | -28.59% | -49.41% | -43.32% | -36.79% | |
| Return on Assets (ROA) | 1.82% | 28.66% | -19.32% | -27.57% | -23.40% | -16.82% | |
| Return on Capital (ROIC) | 1.98% | 30.86% | -21.01% | -31.27% | -26.60% | -21.08% | |
| Return on Capital Employed (ROCE) | 2.90% | 36.30% | -27.80% | -60.60% | -41.40% | -22.70% | |
| Earnings Yield | 0.82% | 11.96% | -5.97% | -23.73% | -7.69% | -7.63% | |
| FCF Yield | 1.14% | 7.95% | -5.36% | -20.29% | -6.68% | -8.41% | |
| Buyback Yield / Dilution | -0.97% | -14.65% | -15.74% | -5.87% | -34.67% | -32.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.